BRST5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
 
(82 intermediate revisions by 5 users not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
__TOC__
==WHO Classification of Tumours of the Breast (5th Edition) Content==
<br />
{| class="wikitable"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Tumours of the Breast (5th Edition) Content</big>
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
Line 17: Line 18:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|-
|Usual Ductal Hyperplasia
|
|Disease
====CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[BRST5:Usual ductal hyperplasia|Usual ductal hyperplasia]]
|Disease
|Ritika Pathak
|2/25/2026
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Atypical Ductal Hyperplasia||Disease||
|[[BRST5:Columnar cell lesions, including flat epithelial atypia|Columnar cell lesions, including flat epithelial atypia]]||Disease||
|
|
|
|
Line 44: Line 60:
|
|
|-
|-
|Sclerosing Adenosis||Disease||
|[[BRST5:Atypical ductal hyperplasia|Atypical ductal hyperplasia]]||Disease||
|
|
|
|
Line 53: Line 69:
|
|
|-
|-
|Apocrine Adenosis and Adenoma||Disease||
|[[BRST5:Sclerosing adenosis|Sclerosing adenosis]]||Disease||
|
|
|
|
Line 62: Line 78:
|
|
|-
|-
|Microglandular Adenosis||Disease||
|[[BRST5:Apocrine adenosis and adenoma|Apocrine adenosis and adenoma]]||Disease||
|
|
|
|
Line 71: Line 87:
|
|
|-
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|[[BRST5:Microglandular adenosis|Microglandular adenosis]]||Disease||
|
|
|
|
Line 80: Line 96:
|
|
|-
|-
|Tubular Adenoma||Disease||
|[[BRST5:Radial scar / complex sclerosing lesion|Radial scar/complex sclerosing lesion]]||Disease||
|
|
|
|
Line 89: Line 105:
|
|
|-
|-
|Lactating Adenoma||Disease||
|[[BRST5:Tubular adenoma|Tubular adenoma]]||Disease||
|
|
|
|
Line 98: Line 114:
|
|
|-
|-
|Ductal Adenoma||Disease||
|[[BRST5:Lactating adenoma|Lactating adenoma]]||Disease||Joanna George
|
|3/28/2026
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Pleomorphic Adenoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Ductal adenoma|Ductal adenoma]]||Disease||
|
|
|
|
Line 116: Line 143:
|
|
|-
|-
|Adenomyoepithelioma||Disease||
|[[BRST5:Pleomorphic adenoma|Pleomorphic adenoma]]||Disease||
|
|
|
|
Line 125: Line 152:
|
|
|-
|-
|Malignant Adenomyoepithelioma||Disease||
|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]||Disease||
|
|
|
|
Line 134: Line 161:
|
|
|-
|-
|Intraductal Papilloma||Disease||
|[[BRST5:Malignant adenomyoepithelioma|Malignant adenomyoepithelioma]]||Disease||
|
|
|
|
Line 143: Line 170:
|
|
|-
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|[[BRST5:Intraductal papilloma|Intraductal papilloma]]||Disease||
|
|
|
|
Line 152: Line 179:
|
|
|-
|-
|Encapsulated Papillary Carcinoma||Disease||
|[[BRST5:Papillary ductal carcinoma in situ|Papillary ductal carcinoma in situ]]||Disease||Sresi Singh (trainee), Katherine Geiersbach
|
|2/26/2026
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|[[BRST5:Encapsulated papillary carcinoma|Encapsulated papillary carcinoma]]||Disease||
|
|
|
|
Line 170: Line 197:
|
|
|-
|-
|Invasive Papillary Carcinoma||Disease||
|[[BRST5:Solid papillary carcinoma (in situ and invasive)|Solid papillary carcinoma (in situ and invasive)]]||Disease||
|
|
|
|
Line 179: Line 206:
|
|
|-
|-
|Atypical Lobular Hyperplasia||Disease||
|[[BRST5:Invasive papillary carcinoma|Invasive papillary carcinoma]]||Disease||
|
|
|
|
Line 188: Line 215:
|
|
|-
|-
|Lobular Carcinoma In Situ||Disease||
|[[BRST5:Atypical lobular hyperplasia|Atypical lobular hyperplasia]]||Disease||
|
|
|
|
Line 197: Line 224:
|
|
|-
|-
|Ductal Carcinoma In Situ||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Lobular carcinoma in situ|Lobular carcinoma in situ]]||Disease||Vaishnavi Devarakonda
|2/19/2026
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|[[BRST5:Ductal carcinoma in situ|Ductal carcinoma in situ]]||Disease||Vaishnavi Devarakonda
|2/19/2026
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|[[BRST5:Invasive breast carcinoma of no special type|Invasive breast carcinoma of no special type]]||Disease||Braa Elwaleed Mohamed Ahmed (trainee) +Katherine to find mentor
|
|2/20/2026
|
|
|
|
|PENDING
|
|
|Katherine Geirsbach
|
|
|
|
|-
|-
|Microinvasive Carcinoma||Disease||
|[[BRST5:Microinvasive carcinoma|Microinvasive carcinoma]]||Disease||
|
|
|
|
Line 224: Line 271:
|
|
|-
|-
|Invasive lobular Carcinoma||Disease||
|[[BRST5:Invasive lobular carcinoma|Invasive lobular carcinoma]]||Disease||
|
|
|
|
Line 233: Line 280:
|
|
|-
|-
|Tubular Carcinoma||Disease||
|[[BRST5:Tubular carcinoma|Tubular carcinoma]]||Disease||Sree Vishmaya
|
|3/20/2026
|
|
|
|
|
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Cribriform Carcinoma||Disease||
|[[BRST5:Cribriform carcinoma|Cribriform carcinoma]]||Disease||
|
|
|
|
Line 251: Line 298:
|
|
|-
|-
|Mucinous Carcinoma||Disease||
|[[BRST5:Mucinous carcinoma|Mucinous carcinoma]]||Disease||
|
|
|
|
Line 260: Line 307:
|
|
|-
|-
|Mucinous Cystadenocarcinoma||Disease||
|[[BRST5:Mucinous cystadenocarcinoma|Mucinous cystadenocarcinoma]]||Disease||
|
|
|
|
Line 269: Line 316:
|
|
|-
|-
|Invasive Micropapillary Carcinoma||Disease||
|[[BRST5:Invasive micropapillary carcinoma|Invasive micropapillary carcinoma]]||Disease||
|
|
|
|
Line 278: Line 325:
|
|
|-
|-
|Carcinoma with Apocrine Differentiation||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Carcinoma with apocrine differentiation|Carcinoma with apocrine differentiation]]||Disease||
|
|
|
|
Line 287: Line 345:
|
|
|-
|-
|Metaplastic Carcinoma||Disease||
|[[BRST5:Metaplastic carcinoma|Metaplastic carcinoma]]||Disease||
|
|
|
|
Line 296: Line 354:
|
|
|-
|-
|Acinic Cell Carcinoma||Disease||
|[[BRST5:Acinic cell carcinoma|Acinic cell carcinoma]]||Disease||
|
|
|
|
Line 305: Line 363:
|
|
|-
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach;
Jun Liao
|10/12/02022
|10/12/02022
|11/11/2023
|11/11/2023
|COMPLETE
|COMPLETE
|
|
|Hui Chen / Katherine Geiersbach
|Katherine Geiersbach
|12/6/2023
|4/16/2025
|2021 template added
|2024 template added
|-
|-
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen;
Katherine Geiersbach
|10/12/2022
|10/12/2022
|11/11/2023
|11/11/2023
|PENDING
|COMPLETE
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|
|4/16/2025
|2021 template added
|2024 template added
|-
|-
|Mucoepidermoid Carcinoma||Disease||
|[[BRST5:Mucoepidermoid carcinoma|Mucoepidermoid carcinoma]]||Disease||
|
|
|
|
Line 332: Line 392:
|
|
|-
|-
|Polymorphous Adenocarcinoma||Disease||
|[[BRST5:Polymorphous adenocarcinoma|Polymorphous adenocarcinoma]]||Disease||
|
|
|
|
Line 341: Line 401:
|
|
|-
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
|[[BRST5:Tall cell carcinoma with reversed polarity|Tall cell carcinoma with reversed polarity]]||Disease||H. Evin Gulbahce
|8/11/2023
|8/11/2023
|10/11/2023
|10/11/2023
Line 347: Line 407:
|
|
|Katherine Geiersbach
|Katherine Geiersbach
|
|4/16/2025
|2021 template added
|2024 template added
|-
|-
|Neuroendocrine Tumour||Disease||
|[[BRST5:Neuroendocrine tumour|Neuroendocrine tumour]]||Disease||
|
|
|
|
Line 359: Line 419:
|
|
|-
|-
|Neuroendocrine Carcinoma||Disease||
|[[BRST5:Neuroendocrine carcinoma|Neuroendocrine carcinoma]]||Disease||
|
|
|
|
Line 368: Line 428:
|
|
|-
|-
|Hamartoma||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
|8/11/2023
|11/11/2023
|PENDING
|
|
|
----
|
|
|2021 template added
----
|-
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
|8/11/2023
|11/11/2023
|PENDING
|
|
----
|
|
----
|
|
|2021 template added
----
|-
|-
|Syringomatous Tumour||Disease||
|[[BRST5:Hamartoma|Hamartoma]]||Disease||
|
|
|
|
Line 404: Line 469:
|
|
|-
|-
|Nipple Adenoma||Disease||
|[[BRST5:Fibroadenoma|Fibroadenoma]]|| Disease||Aamer Ahmed Fairoze (trainee), Katherine Geiersbach as mentor
|
|2/20/2026
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Paget disease of the Breast||Disease||
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde;
|
H. Evin Gulbahce;
|
 
|
Katherine Geiersbach
|
|8/11/2023
|
|11/11/2023
|COMPLETE
|
|
|
|
|1/8/2025
|2024 template added
|-
|-
|Haemangioma||Disease||
|
|
|
|
|
====CHAPTER 4 (TUMOURS OF THE NIPPLE)====
|
|
----
|
|
----
|
|
|-
----
|Angiomatosis||Disease||
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Atypical Vascular Lesions||Disease||
|[[BRST5:Syringomatous tumour|Syringomatous tumour]]||Disease||
|
|
|
|
Line 449: Line 520:
|
|
|-
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|[[BRST5:Nipple adenoma|Nipple adenoma]]||Disease||
|
|
|
|
Line 458: Line 529:
|
|
|-
|-
|Primary Angiosarcoma of the Breast||Disease||
|[[BRST5:Paget disease of the breast|Paget disease of the breast]]||Disease||Aamer Ahmed Fairoze (trainee), Katherine Geiersbach as mentor
|
|2/20/2026
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|Nodular Fasciitis||Disease||
|
|
====CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Myofibroblastoma||Disease||
|
|
|
|
|
|
----
|
|
----
|
|
----
|-
|-
|Desmoid Fibromatosis||Disease||
|[[BRST5:Haemangioma|Haemangioma]]||Disease||
|
|
|
|
Line 494: Line 568:
|
|
|-
|-
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
!'''Disease'''
|8/11/2023
!'''Page Type'''
|11/11/2023
!'''<span style="color:#0070C0">Author'''
|COMPLETE
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|Katherine Geiersbach
!'''Author Content (Pending or Complete)'''
|12/6/2023
!'''Date Completed by Author'''
|2021 template added
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Schwannoma||Disease||
|[[BRST5:Angiomatosis|Angiomatosis]]||Disease||
|
|
|
|
Line 512: Line 588:
|
|
|-
|-
|Neurofibroma||Disease||
|[[BRST5:Atypical vascular lesions|Atypical vascular lesions]]||Disease||
|
|
|
|
Line 521: Line 597:
|
|
|-
|-
|Granular Cell Tumour||Disease||
|[[BRST5:Postradiation angiosarcoma of the breast|Postradiation angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 530: Line 606:
|
|
|-
|-
|Leiomyoma||Disease||
|[[BRST5:Primary angiosarcoma of the breast|Primary angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 539: Line 615:
|
|
|-
|-
|Leiomyosarcoma||Disease||
|[[BRST5:Nodular fasciitis|Nodular fasciitis]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Desmoid fibromatosis|Desmoid fibromatosis]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Inflammatory myofibroblastic tumour|Inflammatory myofibroblastic tumour]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|Migrated page to STBT5.
|-
|[[BRST5:Schwannoma|Schwannoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Neurofibroma|Neurofibroma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Granular cell tumour|Granular cell tumour]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Leiomyoma|Leiomyoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Lipoma||Disease||
|[[BRST5:Leiomyosarcoma|Leiomyosarcoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Lipoma|Lipoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Angiolipoma|Angiolipoma]]||Disease||[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Angiolipoma||Disease||
|[[BRST5:Liposarcoma|Liposarcoma]]||Disease||
|
|
|
|
Line 566: Line 734:
|
|
|-
|-
|Liposarcoma||Disease||
|[[BRST5:Pseudoangiomatous stromal hyperplasia|Pseudoangiomatous stromal hyperplasia]]||Disease||
|
|
|
|
Line 575: Line 743:
|
|
|-
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
====CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Follicular Lymphoma||Disease||
|[[BRST5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|
|
|-
|
|
====CHAPTER 7 (TUMOURS OF THE MALE BREAST)====
|
|
----
|
|
|-
----
|Diffuse Large B-cell Lymphoma||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Burkitt Lymphoma||Disease||
|[[BRST5:Gynaecomastia|Gynaecomastia]]||Disease||
|
|
|
|
Line 620: Line 850:
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|[[BRST5:Carcinoma in situ|Carcinoma in situ]]||Disease||
|
|
|
|
Line 629: Line 859:
|
|
|-
|-
|Gynaecomastia||Disease||
|[[BRST5:Invasive carcinoma|Invasive carcinoma]]||Disease||
|
|
|
|
Line 638: Line 868:
|
|
|-
|-
|Carcinoma In Situ||Disease||
|[[BRST5:Metastases to the breast|Metastases to the breast]]||Disease||
|
|
|
|
Line 647: Line 877:
|
|
|-
|-
|Invasive Carcinoma||Disease||
|
|
====CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Metastases to the Breast||Disease||
|
|
|
|
|
|
----
|
|
----
|
|
----
|-
|[[BRST5:BRCA1/2-associated hereditary breast and ovarian cancer syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
!'''Disease'''
|12/6/2023
!'''Page Type'''
|3/6/2024
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Cowden Syndrome||Disease||
|[[BRST5:Cowden syndrome|Cowden syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship statu]]<nowiki/>s [see [[GTS5:PTEN hamartoma tumour syndrome (PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|12/11/2023
|N/A
|3/11/2024
|N/A
|
|N/A
|
|N/A
|Katherine Geiersbach
|N/A
|
|N/A
|
|
|-
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|[[BRST5:Li-Fraumeni syndrome, TP53-associated|Li-Fraumeni syndrome, TP53-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|[[BRST5:Li-Fraumeni syndrome, CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|CDH1-Associated Breast Cancer||Disease||
|[[BRST5:CDH1-associated breast cancer|CDH1-associated breast cancer]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach
|[[BRST5:PALB2-associated cancers|PALB2-associated cancers]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|12/8/2023
|N/A
|3/8/2024
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|Peutz-Jeghers Syndrome||Disease||
|[[BRST5:Peutz-Jeghers syndrome|Peutz-Jeghers syndrome]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|[[GTS5:Neurofibromatosis type 1 (NF1)|Neurofibromatosis type 1]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Polygenic Component of Breast Cancer Susceptibility
|[[BRST5:Polygenic component of breast cancer susceptibility|Polygenic component of breast cancer susceptibility]]
|Disease
|Disease
|Xiaolin Hu
|6/4/2024
|
|
|
|
Line 753: Line 999:
|
|
|
|
|
|Template added (6/4/24)
|
|
|-
|-
|}<br />
|}<br />

Latest revision as of 07:45, 28 March 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.


WHO Classification of Tumours of the Breast (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)
Usual ductal hyperplasia Disease Ritika Pathak 2/25/2026 PENDING Katherine Geiersbach
Columnar cell lesions, including flat epithelial atypia Disease
Atypical ductal hyperplasia Disease
Sclerosing adenosis Disease
Apocrine adenosis and adenoma Disease
Microglandular adenosis Disease
Radial scar/complex sclerosing lesion Disease
Tubular adenoma Disease
Lactating adenoma Disease Joanna George 3/28/2026 PENDING Katherine Geiersbach
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Ductal adenoma Disease
Pleomorphic adenoma Disease
Adenomyoepithelioma Disease
Malignant adenomyoepithelioma Disease
Intraductal papilloma Disease
Papillary ductal carcinoma in situ Disease Sresi Singh (trainee), Katherine Geiersbach 2/26/2026 PENDING Katherine Geiersbach
Encapsulated papillary carcinoma Disease
Solid papillary carcinoma (in situ and invasive) Disease
Invasive papillary carcinoma Disease
Atypical lobular hyperplasia Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lobular carcinoma in situ Disease Vaishnavi Devarakonda 2/19/2026 PENDING Katherine Geiersbach
Ductal carcinoma in situ Disease Vaishnavi Devarakonda 2/19/2026 PENDING Katherine Geiersbach
Invasive breast carcinoma of no special type Disease Braa Elwaleed Mohamed Ahmed (trainee) +Katherine to find mentor 2/20/2026 PENDING Katherine Geirsbach
Microinvasive carcinoma Disease
Invasive lobular carcinoma Disease
Tubular carcinoma Disease Sree Vishmaya 3/20/2026 Katherine Geiersbach
Cribriform carcinoma Disease
Mucinous carcinoma Disease
Mucinous cystadenocarcinoma Disease
Invasive micropapillary carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Carcinoma with apocrine differentiation Disease
Metaplastic carcinoma Disease
Acinic cell carcinoma Disease
Adenoid cystic carcinoma Disease Katherine Geiersbach;

Jun Liao

10/12/02022 11/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Secretory carcinoma Disease Hui Chen;

Katherine Geiersbach

10/12/2022 11/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Mucoepidermoid carcinoma Disease
Polymorphous adenocarcinoma Disease
Tall cell carcinoma with reversed polarity Disease H. Evin Gulbahce 8/11/2023 10/11/2023 COMPLETE Katherine Geiersbach 4/16/2025 2024 template added
Neuroendocrine tumour Disease
Neuroendocrine carcinoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)
Hamartoma Disease
Fibroadenoma Disease Aamer Ahmed Fairoze (trainee), Katherine Geiersbach as mentor 2/20/2026 PENDING Katherine Geiersbach
Phyllodes tumour Disease Emilie Lalonde;

H. Evin Gulbahce;

Katherine Geiersbach

8/11/2023 11/11/2023 COMPLETE 1/8/2025 2024 template added

CHAPTER 4 (TUMOURS OF THE NIPPLE)
Syringomatous tumour Disease
Nipple adenoma Disease
Paget disease of the breast Disease Aamer Ahmed Fairoze (trainee), Katherine Geiersbach as mentor 2/20/2026 PENDING Katherine Geiersbach

CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)
Haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatosis Disease
Atypical vascular lesions Disease
Postradiation angiosarcoma of the breast Disease
Primary angiosarcoma of the breast Disease
Nodular fasciitis Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Myofibroblastoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Desmoid fibromatosis Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Inflammatory myofibroblastic tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A Migrated page to STBT5.
Schwannoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibroma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Granular cell tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Leiomyoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Leiomyosarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Lipoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Angiolipoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Liposarcoma Disease
Pseudoangiomatous stromal hyperplasia Disease

CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Follicular lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse large B-cell lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Burkitt lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Breast implant-associated anaplastic large cell lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A

CHAPTER 7 (TUMOURS OF THE MALE BREAST)
Gynaecomastia Disease
Carcinoma in situ Disease
Invasive carcinoma Disease
Metastases to the breast Disease

CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)
BRCA1/2-associated hereditary breast and ovarian cancer syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See GTS5 volunteer sheet for authorship status [see PTEN hamartoma tumour syndrome (PTEN)] N/A N/A N/A N/A N/A N/A
Ataxia-telangiectasia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, TP53-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome, CHEK2-associated Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
CDH1-associated breast cancer Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
PALB2-associated cancers Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Polygenic component of breast cancer susceptibility Disease Xiaolin Hu 6/4/2024 Template added (6/4/24)


Retrieved from "https://content.ccga.io/index.php?title=BRST5:Volunteer_Assignments_and_Opportunities&oldid=21057"